Biofilm Formation by Species: A Comparative Study

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2017 Sep 5

PMID 28868050

Citations 23

Authors

Rodrigo Rollin-Pinheiro

Jardel V de Meirelles

Taissa V M Vila

Beatriz B Fonseca

Vinicius Alves

Susana Frases

Sonia Rozental

Eliana Barreto-Bergter

Affiliations

Soon will be listed here.

Abstract

species are medically important fungi that are present in soil and human impacted areas and capable of causing a wide spectrum of diseases in humans. Although little is known about their pathogenesis, their growth process and infection routes are very similar to those of species, which grow as biofilms in invasive infections. All nine strains tested here displayed the ability to grow as biofilms and to produce a dense network of interconnected hyphae on both polystyrene and the surfaces of central venous catheters, but with different characteristics. and clinical isolates were able to form biofilms faster than the corresponding environmental strains, as evidenced in kinetic assays for and CLSM for . Biofilms formed by species had significantly higher resistance to the class of antifungal azole than was observed in planktonic cells, indicating a protective role for this structure. In addition, the clinical isolate that formed the most robust biofilms was also more virulent in a larvae infection model, suggesting that the ability to form biofilms enhances virulence in species.

Citing Articles

Comparison of Soil Microbial Composition in Rhizospheres Between Wilt Disease-Resistant and Susceptible Melon Varieties.

Qiu L, Zhu Y, Li X, Qin Y, Li G, Ye Y Microorganisms. 2025; 13(2).

PMID: 40005810 PMC: 11858135. DOI: 10.3390/microorganisms13020444.

Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections.

Neoh C, Chen S, Lanternier F, Tio S, Halliday C, Kidd S Clin Microbiol Rev. 2024; 37(2):e0000423.

PMID: 38551323 PMC: 11237582. DOI: 10.1128/cmr.00004-23.

Cell dispersion during biofilm formation by and .

Mello T, Barcellos I, Branquinha M, Santos A Curr Res Microb Sci. 2023; 4:100191.

PMID: 37229517 PMC: 10203734. DOI: 10.1016/j.crmicr.2023.100191.

and Effect of the Imidazole Luliconazole against and spp.

Furnica D, Dittmer S, Scharmann U, Meis J, Steinmann J, Rath P Microbiol Spectr. 2023; 11(3):e0513022.

PMID: 37017567 PMC: 10269907. DOI: 10.1128/spectrum.05130-22.

Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms.

Vikelouda K, Simitsopoulou M, Antachopoulos C, Skoura L, Roilides E J Antimicrob Chemother. 2023; 78(4):1076-1083.

PMID: 36848199 PMC: 10068423. DOI: 10.1093/jac/dkad050.

References

Guarro J, Kantarcioglu A, Horre R, Rodriguez-Tudela J, Cuenca Estrella M, Berenguer J . Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol. 2006; 44(4):295-327. DOI: 10.1080/13693780600752507. View

Vila T, Ishida K, De Souza W, Prousis K, Calogeropoulou T, Rozental S . Effect of alkylphospholipids on Candida albicans biofilm formation and maturation. J Antimicrob Chemother. 2012; 68(1):113-25. DOI: 10.1093/jac/dks353. View

Ramage G, Rajendran R, Gutierrez-Correa M, Jones B, Williams C . Aspergillus biofilms: clinical and industrial significance. FEMS Microbiol Lett. 2011; 324(2):89-97. DOI: 10.1111/j.1574-6968.2011.02381.x. View

Tammer I, Tintelnot K, Braun-Dullaeus R, Mawrin C, Scherlach C, Schluter D . Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease--a diagnostic and therapeutic challenge. Int J Infect Dis. 2011; 15(6):e422-9. DOI: 10.1016/j.ijid.2011.03.004. View

Perez R, Smith M, McClendon J, Kim J, Eugenio N . Pseudallescheria boydii brain abscess. Complication of an intravenous catheter. Am J Med. 1988; 84(2):359-62. DOI: 10.1016/0002-9343(88)90441-x. View

Kojic E, Darouiche R . Candida infections of medical devices. Clin Microbiol Rev. 2004; 17(2):255-67. PMC: 387407. DOI: 10.1128/CMR.17.2.255-267.2004. View

Mello T, Aor A, Goncalves D, Seabra S, Branquinha M, Santos A . Assessment of biofilm formation by Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans. Biofouling. 2016; 32(7):737-49. DOI: 10.1080/08927014.2016.1192610. View

Kaur S, Singh S . Biofilm formation by Aspergillus fumigatus. Med Mycol. 2013; 52(1):2-9. DOI: 10.3109/13693786.2013.819592. View

Nunes J, Bizerra F, e Ferreira R, Colombo A . Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates. Antimicrob Agents Chemother. 2012; 57(1):382-9. PMC: 3535921. DOI: 10.1128/AAC.01647-12. View

10.

Rajendran R, Sherry L, Nile C, Sherriff A, Johnson E, Hanson M . Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013. Clin Microbiol Infect. 2015; 22(1):87-93. PMC: 4721535. DOI: 10.1016/j.cmi.2015.09.018. View

11.

Taj-Aldeen S, Salah H, Al-Hatmi A, Hamed M, Theelen B, van Diepeningen A . In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method. Diagn Microbiol Infect Dis. 2016; 85(4):438-43. DOI: 10.1016/j.diagmicrobio.2016.05.006. View

12.

Al-Fattani M, Douglas L . Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol. 2006; 55(Pt 8):999-1008. DOI: 10.1099/jmm.0.46569-0. View

13.

Rougeron A, Schuliar G, Leto J, Sitterle E, Landry D, Bougnoux M . Human-impacted areas of France are environmental reservoirs of the Pseudallescheria boydii/Scedosporium apiospermum species complex. Environ Microbiol. 2014; 17(4):1039-48. DOI: 10.1111/1462-2920.12472. View

14.

Seidler M, Salvenmoser S, Muller F . Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob Agents Chemother. 2008; 52(11):4130-6. PMC: 2573142. DOI: 10.1128/AAC.00234-08. View

15.

Vila T, Chaturvedi A, Rozental S, Lopez-Ribot J . In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis. Antimicrob Agents Chemother. 2015; 59(12):7611-20. PMC: 4649157. DOI: 10.1128/AAC.01890-15. View

16.

Al Refai M, Duhamel C, Le Rochais J, Icard P . Lung scedosporiosis: a differential diagnosis of aspergillosis. Eur J Cardiothorac Surg. 2002; 21(5):938-9. DOI: 10.1016/s1010-7940(02)00068-4. View

17.

Eldin C, Chiche L, Thomas G, Dicostanzo M, Durand J, Harle J . Scedosporium apiospermum catheter-related soft-tissue infection: a case report and review of the literature. Med Mycol. 2011; 50(6):627-30. DOI: 10.3109/13693786.2011.639035. View

18.

Borghi E, Morace G, Borgo F, Rajendran R, Sherry L, Nile C . New strategic insights into managing fungal biofilms. Front Microbiol. 2015; 6:1077. PMC: 4594024. DOI: 10.3389/fmicb.2015.01077. View

19.

Davies D . Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003; 2(2):114-22. DOI: 10.1038/nrd1008. View

20.

Cortez K, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T . Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008; 21(1):157-97. PMC: 2223844. DOI: 10.1128/CMR.00039-07. View